Quick answer
This page lists 26 allogeneic bone marrow transplantation doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Allogeneic Bone Marrow Transplantation doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Allogeneic Bone Marrow Transplantation doctors
FeaturedDr. Rahul Bhargava
MBBS, MD (General Medicine), DM (Clinical Hematology), Advanced Fellowship in Unrelated and Haploidentical Transplant
Principal Director & Chief – Hematology · Specialty: Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Hematologist & BMT Specialist
- Principal Director – Hemato-Oncology, Fortis Memorial Research Institute, Gurugram (2017 – Present)
- Head of Hematology and BMT, Artemis Hospital, Gurugram (2013 – 2016)
Expertise & Procedures
- Autologous Bone Marrow Transplant
- Allogeneic Bone Marrow Transplant
- Haploidentical BMT
- Unrelated Donor BMT
- Peripheral Blood Stem Cell Transplantation
Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Arun Singh Danewa
MBBS, MD (Pediatrics), Pediatric Oncology Training, Fellowship in Bone Marrow Transplantation
Sr. Consultant — Pediatric Hematology, Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Pediatric Hematologist & BMT Specialist
- Senior Consultant — Pediatric Hematology, Oncology, Bone Marrow Transplant, Artemis Hospital, Gurugram (Present)
- Pediatric Oncology Fellowship, Sir Ganga Ram Hospital, New Delhi
Expertise & Procedures
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Haploidentical Stem Cell Transplant
- Matched Sibling Donor Transplant for Thalassemia
- Bone Marrow Aspiration & Biopsy
Pediatric Hematologist & BMT Specialist Experience: 10+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Dr. Vikas Dua
MBBS, MD (Paediatrics), FNB (Paediatric Hematology Oncology), Fellowship in Paediatric Bone Marrow Transplant, Outreach Programme in Paediatric BMT
Principal Director & Head — Paediatric Haematology, Haemato-Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Pediatric Hematologist & BMT Specialist
- Principal Director & Head — Paediatric Haematology, Haemato-Oncology and BMT, Fortis Memorial Research Institute, Gurgaon (Present)
- Senior Consultant — Paediatric Hemato-Oncology and BMT, Artemis Hospital, Gurgaon
Expertise & Procedures
- Allogeneic Bone Marrow Transplant
- Matched Sibling Donor Transplant
- Matched Unrelated Donor Transplant
- Haploidentical Paediatric Stem Cell Transplant
- Autologous Stem Cell Transplant
Pediatric Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Jasmine Porwal
DM, MD, MBBS
Consultant — Medical Oncology and Cancer Care · Specialty: Medical Oncologist
Medanta - The Medicity Gurgaon, India12+ Years experience
Why consider this doctor?
- 12+ years of experience in Medical Oncologist
- Consultant — Medical Oncology and Cancer Care, Medanta — The Medicity, Gurgaon, Present
- Senior Research Fellow, Medical Oncology, AIIMS Delhi (Indian Institute of Rotary Cancer Hospital), New Delhi
Expertise & Procedures
- Chemotherapy for Solid Tumours
- Adjuvant and Neoadjuvant Chemotherapy
- Immunotherapy and Checkpoint Inhibitor Therapy
- Molecular Targeted Therapy
- Haematological Malignancy Management
Medical Oncologist Experience: 12+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Naidu N. Bethune
MBBS, MD, DM
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Hi-Tech City Hyderabad, India21+ Years experience
Why consider this doctor?
- 21+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Yashoda Hospitals, Hi-Tech City, Hyderabad (Present)
- Consultant — Medical Oncology, American Oncology Institute, Hyderabad
Expertise & Procedures
- Chemotherapy Administration for Solid and Hematological Cancers
- Targeted Therapy and Molecular Cancer Treatment
- Cancer Immunotherapy and Checkpoint Inhibitors
- Stem Cell Transplantation
- Bone Marrow Transplantation
Medical Oncologist Experience: 21+ YearsHospital Affiliation: Yashoda Hospitals, Hi-Tech CityHospital accreditation: NABH, NABL
Dr. Rajeev Vijayakumar
MBBS, DNB (General Medicine), DNB (Medical Oncology), MRCP, ESMO Certified
Head of Department & Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Hospitals, Bengaluru Bengaluru, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Medical Oncologist
- Head of Department & Senior Consultant – Medical Oncology, Gleneagles Hospitals, Bengaluru
- Senior Consultant – Hemato-Oncology and Bone Marrow Transplant, Gleneagles Hospitals, Bengaluru
Expertise & Procedures
- Chemotherapy administration and management
- Targeted molecular therapy
- Cancer immunotherapy and immune checkpoint inhibitors
- CAR-T cell therapy
- Bone marrow transplantation
Medical Oncologist Experience: 20+ YearsHospital Affiliation: Gleneagles Hospitals, BengaluruHospital accreditation: NABH
Dr. Viraj Nevrekar
DM in Medical Oncology, MD in Medicine, ECMO Certification
Senior Consultant — Medical Oncology & Bone Marrow Transplant · Specialty: Medical Oncologist & Hemato-Oncologist
Gleneagles Global Hospitals Mumbai, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist & Hemato-Oncologist
- Senior Consultant — Medical Oncology & Bone Marrow Transplant, Gleneagles Global Hospitals, Mumbai, Parel
- Over 11 years of clinical practice in medical oncology and hemato-oncology across leading Indian hospital networks
Expertise & Procedures
- Allogeneic Bone Marrow Transplantation
- Autologous Stem Cell Transplantation
- High-dose Chemotherapy Regimens
- Cancer Immunotherapy and CAR-T Cell Therapy
- Targeted Molecular Therapy for Solid Tumors
Medical Oncologist & Hemato-Oncologist Experience: 11+ YearsHospital Affiliation: Gleneagles Global HospitalsHospital accreditation: NABH, JCI
Dr. Ajay Gupta
MBBS, MD, DM, FRACP, Fellowship in Pediatric Bone Marrow Transplantation, Fellowship in Leukemia and Bone Marrow Transplantation
Senior Consultant — Hematology · Specialty: Hematologist & Bone Marrow Transplant Specialist
Indraprastha Apollo Hospital New Delhi, India17+ Years experience
Why consider this doctor?
- 17+ years of experience in Hematologist & Bone Marrow Transplant Specialist
- Senior Consultant — Hematology, Indraprastha Apollo Hospital, New Delhi — Present
- Specialist in Bone Marrow Transplantation and Leukemia Management — Indraprastha Apollo Hospital, New Delhi
Expertise & Procedures
- Allogeneic Bone Marrow Transplantation
- Autologous Stem Cell Transplantation
- Haploidentical Bone Marrow Transplantation
- Peripheral Blood Stem Cell Mobilization and Harvesting
- Pediatric Bone Marrow Transplantation
Hematologist & Bone Marrow Transplant Specialist Experience: 17+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Dr. Anamika Bakliwal
MBBS, MD (Paediatrics), DM (Clinical Haematology — Adult & Paediatrics)
Consultant — Haemato-oncology & Bone Marrow Transplant · Specialty: Paediatric Haematologist & Bone Marrow Transplant Specialist
BLK-Max Super Speciality Hospital New Delhi, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Paediatric Haematologist & Bone Marrow Transplant Specialist
- Consultant — Haemato-oncology & Bone Marrow Transplant, BLK-Max Super Speciality Hospital, New Delhi (Present)
- Senior Consultant, Sri Balaji Action Cancer Institute, Paschim Vihar, New Delhi
Expertise & Procedures
- Allogeneic bone marrow transplantation
- Autologous bone marrow transplantation
- Haploidentical bone marrow transplantation
- Peripheral blood stem cell mobilisation and collection
- Bone marrow aspiration and biopsy
Paediatric Haematologist & Bone Marrow Transplant Specialist Experience: 10+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Dr. Dharma Choudhary
MBBS, MD (Internal Medicine), DM (Clinical Haematology)
Chairman — Haemato Oncology & Bone Marrow Transplant · Specialty: Haemato-Oncologist & Bone Marrow Transplant Specialist
BLK-Max Super Speciality Hospital New Delhi, India23+ Years experience
Why consider this doctor?
- 23+ years of experience in Haemato-Oncologist & Bone Marrow Transplant Specialist
- Chairman, Haemato-Oncology & Bone Marrow Transplant, BLK-Max Super Speciality Hospital, New Delhi — Present
- Director & HOD, Blood & Marrow Transplant, Sanar International Hospital, Gurgaon, Haryana
Expertise & Procedures
- Allogeneic Bone Marrow Transplantation
- Autologous Bone Marrow Transplantation
- Haploidentical Bone Marrow Transplant
- Matched Sibling Donor Transplant
- Bone Marrow Harvest and Evaluation
Haemato-Oncologist & Bone Marrow Transplant Specialist Experience: 23+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 Gurgaon, IndiaStarting from$28,000
Artemis Hospital
Est. 2007
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Allogeneic Bone Marrow TransplantationCardiac SurgeryCardiologyMedical Oncology
3+
Doctors for Allogeneic Bone Marrow Transplantation
4.9
64 reviews
750+
Beds
19+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$28,000
Fortis Memorial Research Institute
Est. 1996
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Allogeneic Bone Marrow TransplantationCardiac SurgeryCardiologyMedical Oncology
1+
Doctors for Allogeneic Bone Marrow Transplantation
4.8
1100 reviews
1000+
Beds
30+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$28,000
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Allogeneic Bone Marrow TransplantationCardiac SurgeryCardiologyMedical Oncology
3+
Doctors for Allogeneic Bone Marrow Transplantation
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 Hitec City, Hyderabad, IndiaStarting from$28,000
Medicover Hospital Hitec City
Est. 2011
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Allogeneic Bone Marrow TransplantationCardiac SurgeryCardiologyMedical Oncology
1+
Doctors for Allogeneic Bone Marrow Transplantation
4.3
95 reviews
250+
Beds
15+
Years Since Founded
🇮🇳 Parel, Mumbai, IndiaStarting from$28,000
Gleneagles Global Hospitals (Global Hospitals)
Est. 1996
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Allogeneic Bone Marrow TransplantationLiver TransplantCardiac SurgeryOrthopedics
1+
Doctors for Allogeneic Bone Marrow Transplantation
4.6
183 reviews
450+
Beds
30+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$28,000
Apollo Hospitals
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Allogeneic Bone Marrow TransplantationCardiac SurgeryCardiologyMedical Oncology
2+
Doctors for Allogeneic Bone Marrow Transplantation
4.9
1240 reviews
1000+
Beds
43+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$28,000
BLK-Max Super Speciality Hospital
Est. 1959
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Allogeneic Bone Marrow TransplantationCardiac SurgeryCardiologyMedical Oncology
4+
Doctors for Allogeneic Bone Marrow Transplantation
3.8
48 reviews
650+
Beds
67+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for myelodysplastic syndromes treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Allogeneic Bone Marrow Transplantation?
Allogeneic Bone Marrow Transplantation (allo-BMT) involves replacing a patient's diseased or non-functioning bone marrow with healthy blood-forming stem cells from a matched donor. It is a curative option for conditions such as Myelodysplastic Syndromes (MDS) and severe Aplastic Anemia, where the patient's own marrow fails to produce healthy blood cells. The procedure requires conditioning chemotherapy/radiation, stem cell infusion, and prolonged monitoring for engraftment and immune recovery.
Who may be considered?
Allogeneic Bone Marrow Transplantation may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Stem cells are collected from a fully or closely HLA-matched sibling or family member, offering the lowest risk of graft rejection and graft-versus-host disease among allogeneic options.
2 approaches available for this procedure:
Matched Related Donor (MRD) Allogeneic BMT
Most CommonStem cells are collected from a fully or closely HLA-matched sibling or family member, offering the lowest risk of graft rejection and graft-versus-host disease among allogeneic options.
Comprehensive Investigations
Estimated cost: $800 - $2,000
HLA typing (patient and donor), CBC with differential, bone marrow biopsy and aspirate, cytogenetics/FISH, viral serology (HIV, Hepatitis B/C, CMV), ECG, chest X-ray, pulmonary function test, kidney and liver function tests
Treatment / Procedure Estimate
Estimated cost in India: $28,000 - $45,000
Stay in India
Pre-procedure stay (outside hospital): ~5-7 days
Hospitalisation: ~25-35 days
Recovery period (outside hospital): ~90-100 days recommended
Total stay: approx 100-120 days
Usually Included in Hospital Package
- Pre-transplant conditioning chemotherapy/radiation
- Stem cell harvest from donor and infusion
- Isolation room/HEPA-filtered ward stay
- Daily monitoring, transfusions, and supportive medications
- Coordination with transplant physician and nursing team
Usually Not Included
- Donor travel and screening costs (if international)
- Post-discharge medications and immunosuppressants
- Treatment of severe graft-versus-host disease if it occurs
- Long-term follow-up visits after return to home country
- Accommodation for attendant beyond hospital stay
Recovery and follow-up
Patients typically remain in India for 3-5 months for engraftment monitoring, immune recovery, and management of early complications before returning home with a structured follow-up plan and local hematologist coordination.
Risks
Key risks include graft-versus-host disease (acute or chronic), graft failure, severe infections due to immunosuppression, and organ toxicity from conditioning therapy.
Alternatives
Depending on disease severity, alternatives may include immunosuppressive therapy, hypomethylating agents, supportive transfusion therapy, or autologous stem cell approaches, though these are typically less curative for high-risk MDS or severe aplastic anemia.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Complete blood count (CBC) with peripheral smear
- Bone marrow biopsy and aspirate report with cytogenetics
- HLA typing report of patient and potential donor(s)
- Viral serology panel (HIV, Hepatitis B/C, CMV, EBV)
- Recent chest X-ray or CT scan
- Cardiac evaluation (ECG, echocardiogram)
- Liver and kidney function test results
- Prior treatment history and transfusion records
Patient information needed
- Confirmed diagnosis (MDS subtype or severity grade of aplastic anemia)
- Age, weight, and current performance status
- Availability and HLA typing status of potential donors
- History of previous transfusions or chemotherapy
- Current medications and known allergies
- Any active infections or comorbid conditions
- Insurance or payment method for treatment planning
- Attendant/caregiver availability for extended stay in India
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Allogeneic Bone Marrow Transplantation) and procedure (Allogeneic Bone Marrow Transplantation) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Allogeneic Bone Marrow Transplantation in India
What is Myelodysplastic Syndromes?
Myelodysplastic syndromes are a family of clonal bone marrow disorders characterised by abnormal blood cell production, resulting in low or dysfunctional blood cell counts and, in some subtypes, a meaningful risk of progression to acute leukaemia.
What are the symptoms and health risks of Myelodysplastic Syndromes?
Common symptoms include persistent fatigue and breathlessness (from anaemia), a tendency to bruise or bleed easily (from low platelets), and recurrent or difficult-to-clear infections (from reduced or poorly functioning white blood cells). Some individuals have minimal symptoms at diagnosis and are identified incidentally through routine blood tests. Symptoms alone are not sufficient to diagnose MDS, as many conditions can produce similar blood count abnormalities.
How is Myelodysplastic Syndromes diagnosed?
Diagnosis typically begins with a full blood count revealing one or more cytopenias, followed by a bone marrow aspirate and trephine biopsy to examine cell morphology and blast percentage. Cytogenetic analysis — and increasingly, molecular genetic testing for mutations in genes such as SF3B1, ASXL1, or TP53 — is central to classifying MDS and assigning a risk score. The Revised International Prognostic Scoring System (IPSS-R) integrates blast count, cytogenetics, haemoglobin, platelet count, and neutrophil count to stratify patients into risk categories that directly inform treatment planning; only a qualified haematologist can interpret these findings in the context of an individual patient's full clinical picture.
How is Myelodysplastic Syndromes treated?
Treatment approach depends heavily on the IPSS-R risk category, the patient's age, overall fitness, and the presence of specific molecular mutations. Lower-risk MDS may be managed with supportive care, growth factors, or disease-modifying agents for months to years before any escalation is considered, whereas higher-risk MDS often warrants more intensive intervention. For eligible patients, allogeneic bone marrow (stem cell) transplantation is currently the only treatment with curative potential, though the decision to proceed requires careful assessment of donor availability, transplant-related risks, and the patient's overall health status.
Can Myelodysplastic Syndromes be treated without a procedure?
Non-procedural management plays a central role in lower-risk MDS and includes regular monitoring with blood counts, red cell or platelet transfusions to manage cytopenias, erythropoiesis-stimulating agents (ESAs) to reduce transfusion dependence, and hypomethylating agents such as azacitidine or decitabine, which can improve blood counts and delay disease progression. Lenalidomide is an established option for a specific subtype associated with the del(5q) chromosomal abnormality. These approaches do not cure MDS in most cases, but they can meaningfully improve quality of life and are an appropriate long-term strategy for many patients, particularly those who are not candidates for transplantation.
When is Allogeneic Bone Marrow Transplantation considered for Myelodysplastic Syndromes?
Allogeneic Bone Marrow Transplantation may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Myelodysplastic Syndromes?
MDS is primarily evaluated and managed by a haematologist with expertise in bone marrow disorders and myeloid malignancies; patients being considered for transplantation are co-managed by a haematologist and a bone marrow transplant (BMT) specialist, ideally within a centre that has a dedicated transplant programme.
How do I choose a doctor for Myelodysplastic Syndromes?
When comparing providers, look for a haematologist or BMT centre with a documented volume of MDS cases and transplant procedures, access to comprehensive cytogenetic and molecular diagnostic services, a multidisciplinary team that includes transplant physicians, infectious disease specialists, and supportive care nurses, and a clear protocol for long-term follow-up and graft-versus-host disease management if transplantation is undertaken.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.